Latest パチスロ 123
- January 5, 2026
- パチスロ 123 and Lunatus Enter into Distribution Agreement for Lasvic Tablets in Nine Middle Eastern Countries
- November 19, 2025
- World's First Mitochondrial Disease Treatment 'MA-5' Commences Phase II Clinical Trial
- November 7, 2025
- Consolidated Financial パチスロ 123 for the Six Months Ended September 30, 2025) [Japanese GAAP]
- November 7, 2025
- Consolidated Financial パチスロ 123 for Second Quarter (Interim Period) of FY2025 - Supplementary Information
- October 16, 2025
- Announcement of Presentation in Academic Conference Regarding Result of Specified Clinical Trial using Digital Therapeutics for Tinnitus
- October 1, 2025
- パチスロ 123 and Hinge Bio Enter into a Collaboration and License Agreement of HB2198 in Japan for SLE and other diseases
- September 16, 2025
- Topline パチスロ 123 from Phase 3 Clinical Study of KRP-R120 for Interstitial Lung Disease
- July 31, 2025
- Summary of Consolidated Financial パチスロ 123 (For the First Quarter ended June 30, 2025) [Under Japanese GAAP]
- July 31, 2025
- First Quarter Consolidated Financial パチスロ 123 for the Fiscal Year Ending March 31, 2026
- May 21, 2025
- Notice of Dividends from Retained Earnings
- May 12, 2025
- Summary of Consolidated Financial パチスロ 123(For fiscal year ended March 31, 2025) [Japanese GAAP]
- May 12, 2025
- Consolidated Financial パチスロ 123 for the Fiscal Year Ended March 31, 2025 (May 12 2025) - Supplementary Information
- May 12, 2025
- Notice Regarding Cancellation of Treasury Stock
- May 12, 2025
- Announcement of Executive Personnel Changes
- April 23, 2025
- Notice of Upward Revisions to Earnings Forecasts
- February 25, 2025
- Digital Therapeutic Development for Chronic Cough Treatment
- February 18, 2025
- パチスロ 123 and Cyrano Therapeutics Enter into an Option Agreement for CYR-064 for the Treatment of Post-Viral Loss of Smell in Japan
- February 5, 2025
- Consolidated Financial パチスロ 123 for the Nine Months Ended December 31, 2024) [Japanese GAAP]
- February 5, 2025
- Consolidated Financial パチスロ 123 for Third Quarter of FY2024 - Supplementary Information
- December 16, 2024
- パチスロ 123 and Bayer Enter into License Agreement for Novel Obstructive Sleep Apnea (OSA) Treatment
- December 6, 2024
- Notice of the relocation of the Nishinihon Distribution Center
- November 7, 2024
- Consolidated Financial パチスロ 123 for the Six Months Ended September 30, 2024) [Japanese GAAP]
- November 7, 2024
- Consolidated Financial パチスロ 123 for Second Quarter (Interim Period) of FY2024 - Supplementary Information
- August 2, 2024
- Option Agreement for drug discovery of extracellular vesicles derived from airway epithelial cells
- July 31, 2024
- Summary of Consolidated Financial パチスロ 123(For the first quarter ended June 30, 2024) [Japanese GAAP]
- July 31, 2024
- 1Q Consolidated Financial パチスロ 123 for the Fiscal Year Ending March 31, 2025 (September 31, 2024) - Supplementary Information
- May 21, 2024
- Notice of Dividends of Retained Earnings
- May 10, 2024
- Summary of Consolidated Financial パチスロ 123(For fiscal year ended March 31, 2024) [Japanese GAAP]
- May 10, 2024
- Consolidated Financial パチスロ 123 for the Fiscal Year Ended March 31, 2024 (May 10 2024) - Supplementary Information
- April 15, 2024
- Starting Date of Operation at the New Head Office
- February 6, 2024
- Summary of Consolidated Financial パチスロ 123(For third quarter ended December 31, 2023) [Japanese GAAP]
- February 6, 2024
- Third Quarter Consolidated Financial パチスロ 123 for the Fiscal Year Ending March 31, 2024 (Feb 6, 2024) - Supplementary Information
- December 8, 2023
- Imidafenacin for Overactive Bladder Launched in Mexico
- November 8, 2023
- Summary of Consolidated Financial パチスロ 123(For second quarter ended September 30, 2023) [Japanese GAAP]
- November 8, 2023
- Second Quarter Consolidated Financial パチスロ 123 for the Fiscal Year Ending March 31, 2024 (Nov 8, 2022) - Supplementary Information
- November 8, 2023
- Notice of differences between Forecasts and Actual パチスロ 123
- September 29, 2023
- Notice Regarding Implementation of voluntary Retirement Program
- August 2, 2023
- Summary of Consolidated Financial パチスロ 123(For the first quarter ended June 30, 2023) [Japanese GAAP]
- August 2, 2023
- 1Q Consolidated Financial パチスロ 123 for the Fiscal Year Ending March 31, 2024 (August 02, 2023) - Supplementary Information
- May 22, 2023
- Notice of Dividends of Retained Earnings
- May 11, 2023
- Summary of Consolidated Financial パチスロ 123(For fiscal year ended May 11, 2023) [Japanese GAAP]